Articles with public access mandates - Andrea AntinoriLearn more
Not available anywhere: 24
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis
A De Luca, A Ammassari, P Pezzotti, P Cinque, J Gasnault, J Berenguer, ...
Aids 22 (14), 1759-1767, 2008
Mandates: US National Institutes of Health
Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients
T Chiacchio, E Petruccioli, V Vanini, G Cuzzi, C Pinnetti, A Sampaolesi, ...
Journal of Infection 69 (6), 533-545, 2014
Mandates: Government of Italy
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009
Antiretroviral Therapy Cohort Collaboration (ART-CC
Aids 27 (5), 803-813, 2013
Mandates: Swiss National Science Foundation, Canadian Institutes of Health Research …
Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS
A Winston, A Antinori, P Cinque, HS Fox, M Gisslen, TJ Henrich, ...
Aids 33, S107-S111, 2019
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
M Zaccarelli, MM Santoro, D Armenia, V Borghi, W Gennari, C Gori, ...
Journal of Clinical Virology 82, 94-100, 2016
Mandates: Government of Italy
UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
S Notari, M Tempestilli, G Fabbri, R Libertone, A Antinori, A Ammassari, ...
Journal of Chromatography B 1073, 183-190, 2018
Mandates: Government of Italy
Timed short messaging service improves adherence and virological outcomes in HIV-1–infected patients with suboptimal adherence to antiretroviral therapy
A Ammassari, MP Trotta, N Shalev, MC Tettoni, S Maschi, F Di Sora, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (4), e113-e115, 2011
Mandates: Government of Spain
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment
D Armenia, M Zaccarelli, V Borghi, W Gennari, D Di Carlo, A Giannetti, ...
Journal of Clinical Virology 104, 61-64, 2018
Mandates: Government of Italy
Impact of ART on dynamics of growth factors and cytokines in primary HIV infection
V Bordoni, A Sacchi, R Casetti, E Cimini, E Tartaglia, C Pinnetti, A Mondi, ...
Cytokine 125, 154839, 2020
Mandates: Government of Italy
In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals
N Tumino, R Casetti, G Fabbri, E Cimini, A Romanelli, F Turchi, O Forini, ...
Journal of Hepatology 67 (2), 422-424, 2017
Mandates: Government of Italy
Polyclonal serum-free light chains elevation in HIV-infected patients
M Bibas, P Lorenzini, A Cozzi-Lepri, A Calcagno, S Di Giambenedetto, ...
AIDS 26 (16), 2107-2110, 2012
Mandates: US National Institutes of Health
HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection
R Casetti, C Pinnetti, A Sacchi, G De Simone, V Bordoni, E Cimini, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (3), 338-344, 2017
Mandates: Government of Italy
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy
L Fabeni, C Alteri, G Berno, R Scutari, N Orchi, G De Carli, A Bertoli, ...
Sexually Transmitted Infections 95 (8), 619-625, 2019
Mandates: Government of Italy
Temporary neurocognitive impairment with Ebola virus
E Nicastri, P Balestra, M Ricottini, N Petrosillo, A Di Caro, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (12), 1386-1387, 2016
Mandates: Government of Italy
Development and validation of an HPLC‐UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV …
M Tempestilli, A Ammassari, A D'Avolio, S Cicalini, AL Gallo, S Fazio, ...
Biomedical Chromatography 32 (9), e4274, 2018
Mandates: Government of Italy
IL-18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV-infected patients treated during primary HIV infection
V Bordoni, D Viola, A Sacchi, C Pinnetti, R Casetti, E Cimini, N Tumino, ...
Cytokine 103, 34-37, 2018
Mandates: Government of Italy
Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment
R Bellagamba, ML Giancola, C Tommasi, P Piselli, M Tempestilli, ...
Aids 33 (3), 493-502, 2019
Mandates: Government of Italy
Prevalence and associated factors of neurocognitive impairment in HIV-positive patients on effective efavirenz/emtricitabine/tenofovir disoproxil fumarate treatment
ML Giancola, P Balestra, A Ammassari, M Ricottini, P Lorenzini, ...
AIDS Research and Human Retroviruses 34 (11), 907-908, 2018
Mandates: Government of Italy
Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV
M Tempestilli, A D’Avolio, A De Nicolò, C Agrati, A Antinori, S Cicalini
Journal of Antimicrobial Chemotherapy 76 (12), 3320-3322, 2021
Mandates: European Commission, Government of Italy
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+ emtricitabine-containing HAART both in vivo and in vitro
C Alteri, M Surdo, VC Di Maio, F Di Santo, G Costa, L Parrotta, I Romeo, ...
Journal of Global Antimicrobial Resistance 7, 1-7, 2016
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program